David Mountcastle Sells 6,391 Shares of Privia Health Group (NASDAQ:PRVA) Stock

Privia Health Group, Inc. (NASDAQ:PRVA) CFO David Mountcastle sold 6,391 shares of the business’s stock in a transaction dated Monday, March 16th. The stock was sold at an average price of $22.11, for a total transaction of $141,305.01. Following the completion of the sale, the chief financial officer directly owned 220,413 shares of the company’s stock, valued at $4,873,331.43. The trade was a 2.82% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink.

David Mountcastle also recently made the following trade(s):

• On Friday, March 13th, David Mountcastle sold 6,565 shares of Privia Health Group stock. The stock was sold at an average price of $21.52, for a total transaction of $141,278.80.
• On Thursday, March 12th, David Mountcastle sold 6,453 shares of Privia Health Group stock. The stock was sold at an average price of $21.90, for a total value of $141,320.70.
• On Monday, March 9th, David Mountcastle sold 5,829 shares of Privia Health Group stock. The shares were sold at an average price of $22.84, for a total value of $133,134.36.
• On Friday, March 6th, David Mountcastle sold 5,177 shares of Privia Health Group stock. The shares were sold at an average price of $23.15, for a total value of $119,847.55.
• On Thursday, February 26th, David Mountcastle sold 5,361 shares of Privia Health Group stock. The stock was sold at an average price of $25.00, for a total value of $134,025.00.
• On Friday, February 27th, David Mountcastle sold 7,697 shares of Privia Health Group stock. The stock was sold at an average price of $25.05, for a total value of $192,809.85.

Privia Health Group Stock Down 2.3%

Shares of PRVA traded down $0.51 during mid-day trading on Wednesday, hitting $21.59. The stock had a trading volume of 1,112,897 shares, compared to its average volume of 813,190. Privia Health Group, Inc. has a fifty-two week low of $18.77 and a fifty-two week high of $26.51. The company has a market cap of $2.67 billion, a PE ratio of 127.00, a PEG ratio of 1.38 and a beta of 0.82. The company’s fifty day simple moving average is $22.80 and its two-hundred day simple moving average is $23.61.

Privia Health Group (NASDAQ:PRVA) last posted its quarterly earnings results on Thursday, February 26th. The company reported $0.25 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.04 by $0.21. Privia Health Group had a return on equity of 3.06% and a net margin of 1.08%.The business had revenue of $541.17 million for the quarter, compared to analyst estimates of $516.61 million. During the same period in the prior year, the company posted $0.21 EPS. The business’s revenue was up 17.4% compared to the same quarter last year. Equities analysts expect that Privia Health Group, Inc. will post 0.14 earnings per share for the current year.

Institutional Investors Weigh In On Privia Health Group

Several large investors have recently made changes to their positions in the company. Bayban acquired a new position in shares of Privia Health Group during the fourth quarter worth approximately $26,000. Invesco Ltd. increased its position in Privia Health Group by 5.1% in the 4th quarter. Invesco Ltd. now owns 427,615 shares of the company’s stock valued at $10,139,000 after acquiring an additional 20,652 shares during the period. Wellington Management Group LLP raised its stake in Privia Health Group by 3.8% during the 4th quarter. Wellington Management Group LLP now owns 233,446 shares of the company’s stock valued at $5,535,000 after acquiring an additional 8,531 shares in the last quarter. Millennium Management LLC boosted its position in Privia Health Group by 19.0% during the 4th quarter. Millennium Management LLC now owns 702,744 shares of the company’s stock worth $16,662,000 after acquiring an additional 112,428 shares during the period. Finally, Gotham Asset Management LLC boosted its position in Privia Health Group by 22.4% during the 4th quarter. Gotham Asset Management LLC now owns 36,995 shares of the company’s stock worth $877,000 after acquiring an additional 6,773 shares during the period. Institutional investors and hedge funds own 94.48% of the company’s stock.

Analyst Ratings Changes

A number of research firms have recently issued reports on PRVA. Stephens restated an “overweight” rating and issued a $32.00 price target on shares of Privia Health Group in a research report on Thursday, December 4th. Wolfe Research set a $31.00 price objective on shares of Privia Health Group in a research report on Tuesday, January 6th. Royal Bank Of Canada initiated coverage on shares of Privia Health Group in a research note on Friday, January 9th. They set an “outperform” rating and a $31.00 price objective on the stock. Canaccord Genuity Group lifted their target price on Privia Health Group from $34.00 to $35.00 and gave the company a “buy” rating in a research note on Friday, February 27th. Finally, Jefferies Financial Group reaffirmed a “buy” rating and set a $32.00 target price on shares of Privia Health Group in a report on Thursday, February 26th. Thirteen analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the stock. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus target price of $31.00.

About Privia Health Group

Privia Health Group (NASDAQ: PRVA) is a physician enablement company that partners with independent physicians, medical groups and health systems to transform the delivery of patient care. Through a clinically integrated network and a proprietary technology platform, the company supports providers in managing population health, delivering coordinated care and optimizing financial performance under both fee-for-service and value-based reimbursement models.

Founded in 2016 and headquartered in McLean, Virginia, Privia Health has rapidly expanded its footprint to serve multiple metropolitan markets across the United States.